Company & Sponsor Intelligence
Unity Health Toronto
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting1
Completed2
Countries1
Therapeutic footprint
autismdepressionother_neurology
Indexed studies
NCT03327129Identifying the Neural Basis of Capability for Suicide
depression · CanadaSUSPENDED
depression · CanadaSUSPENDED
NCT04259671Exploring the Efficacy and Usability of the My Autism Passport (MAP).
autism · CanadaNA
autism · CanadaNA
NCT02636218Ketamine Infusion in Neurologic Deficit
other_neurology · CanadaPHASE2, PHASE3
other_neurology · CanadaPHASE2, PHASE3
NCT06843187Lemborexant for the Treatment of Residual Insomnia in Major Depressive Disorder (MDD)
depression · CanadaPHASE2
depression · CanadaPHASE2
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →